Related Experiment Video
Updated: Jun 12, 2026

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
Published on: May 6, 2016
A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease
J Ochoa-Repáraz1, D W Mielcarz, Y Wang
1Department of Medicine and Neurology, Dartmouth Medical School, Lebanon, New Hampshire, USA. javier.ochoa-reparaz@dartmouth.edu
Abstract:
The intestinal microbiome may have a critical roll in susceptibility or resistance to immune-mediated diseases. Alterations of the gut microflora after oral antibiotic treatment can regulate encephalomyelitis (EAE), an animal model for human multiple sclerosis (MS). We now show that a zwitterionic capsular polysaccharide A (PSA) of Bacteroides fragilis can protect against central nervous system demyelinating disease. Oral administration with purified PSA protected mice against EAE prophylactic and therapeutically. PSA treatment enhanced CD103 expressing dendritic cells (DCs) that accumulated in the cervical lymph nodes. Exposure of naïve DCs to PSA induced the conversion of naïve CD4(+) T cells into interleukin (IL)-10-producing FoxP3(+)Treg cells. Protection against EAE was completely abrogated in IL-10-deficient mice. Our results show an important role for a molecule from human commensal bacteria in protecting against EAE and suggest the possibility for protection in MS.
Insights
Bacteroides fragilis polysaccharide A (PSA) protects against experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS). PSA promotes IL-10 producing regulatory T cells, offering a potential therapeutic strategy for immune-mediated diseases.
Area of Science:
- Microbiology
- Immunology
- Neuroscience
Background:
- The gut microbiome influences immune-mediated diseases.
- Gut microflora alterations impact experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS).
Purpose of the Study:
- To investigate the protective role of polysaccharide A (PSA) from Bacteroides fragilis against EAE.
- To elucidate the immunomodulatory mechanisms of PSA in EAE.
Main Methods:
- Oral administration of purified PSA to mice.
- Analysis of dendritic cell (DC) populations and T cell differentiation.
- Assessment of EAE development in IL-10-deficient mice.
Main Results:
- Purified PSA conferred prophylactic and therapeutic protection against EAE.
- PSA treatment increased CD103+ DCs in cervical lymph nodes.
- PSA induced the differentiation of naïve CD4+ T cells into IL-10-producing FoxP3+ regulatory T cells (Tregs).
- Protection was abolished in IL-10-deficient mice.
Conclusions:
- Bacteroides fragilis PSA protects against EAE.
- PSA-mediated protection involves the induction of IL-10-producing Tregs.
- PSA represents a potential therapeutic agent for MS and other immune-mediated diseases.
More Related Videos
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Meningitis II: Pathophysiology
Gut-Brain Axis
Colonisation of Pathogens
Bacterial Meningitis
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...

